Repligen completes acquisition of BioLife Solutions
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BioLife Solutions Inc (BLFS)
The BioLife Solutions share price today is 38.61, view NASDAQ BLFS stock exchange data. Track the latest BioLife Solutions share price with real-time updates on BLFS stock performance including market cap, day range, 52-week range and dividend yield. Access BLFS charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
38.61
+1.31(+3.51%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
36.95
38.83
52 wk Range
17.86
39.76
Showing BioLife Solutions historical data. For real-time data please try another search
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
36.9538.83
52 wk Range
17.8639.76
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BLFS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Form 8K BioLife Solutions Inc For: 10 September- Investing.com
- Form 4 BioLife Solutions Inc For: 23 September
- Investing.com
- Repligen completes acquisition of BioLife Solutions
- Investing.com
- Form 4 BioLife Solutions Inc For: 23 September
- Investing.com
Form 4 BioLife Solutions Inc For: 23 September- Investing.com
Biolife Solutions stock hits 52-week high at $38.10- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
BioLife Solutions Inc Earnings Call Summary for Q1/2026
- Q1 2026 revenue hit $27.5M, up 25% YoY and beating forecasts by 7.09%; EPS of $0.02 met expectations with GAAP net income of $1.2M.
- Biopreservation Media franchise drove growth, accounting for 85%+ of revenue; stock surged 6.39% aftermarket to $22.20.
- Gross margin declined to 64% from 67% due to temporary manufacturing yield issues; management expects resolution and margin expansion ahead.
- Company maintains full-year revenue growth guidance of 17-20%; quarterly EPS projected to rise from $0.03 in Q2 to $0.06 in Q4 2026.
- Analysts maintain strong buy consensus with $30-34 price targets; company expects profitability despite elevated R&D and operational expenses.
Last Updated: 08-05-2026, 06:10 am
Read Full TranscriptEarnings
Latest Release
06-08-2026
EPS / Forecast
0.91 / 0.03
Revenue / Forecast
28.5M / 27.51M
Compare BLFS to Peers and Sector
Metrics to compare | BLFS | Peers Peers - average of corresponding metrics from companies closely matching BLFS: | Sector Sector - Average of metrics from a broad group of related sector companies | Relationship RelationshipBLFSPeersSector |
|---|---|---|---|---|
P/E Ratio | 38.4x | 0.0x | −0.3x | |
PEG Ratio | 0.04 | 0.00 | 0.00 | |
Price/Book | 4.5x | 0.0x | 2.6x | |
Price / LTM Sales | 17.7x | 0.0x | 2.9x | |
Upside (Analyst Target) | −19.0% | 0.0% | 64.3% | |
Fair Value Upside | Unlock | 0.0% | 10.0% | Unlock |
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.